Form 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 11, 2003

 

MOLINA HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   1-31719   13-4204626
(State of incorporation)  

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

One Golden Shore Drive, Long Beach, California 90802

(Address of principal executive offices)

 

Registrant’s telephone number, including area code: (562) 435-3666

 



Item 7.    Financial Statements and Exhibits.

 

(c)    Exhibits.

 

Exhibit No.

  

Description


99.1   

Press release of Molina Healthcare, Inc. issued August 11, 2003 as to financial results for the quarter ended June 30, 2003.

 

Item 12.    Disclosure of Results of Operations and Financial Condition.

 

On August 11, 2003, we issued a press release announcing our financial results for the quarter ended June 30, 2003. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the websites cited in the press release is not part of this report.

 

The information in this Form 8-K and the exhibit attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

        MOLINA HEALTHCARE, INC.
Date: August 11, 2003   By:   /s/    J. MARIO MOLINA, M.D.
     
       

J. Mario Molina M.D.

Chairman of the Board, Chief

Executive Officer and President

 

2